The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive data.
This move was revealed after a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson has since clarified that the US was demanding access to genetic material for research and profit while refused to guarantee the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more dialogue to reach a deal suitable to all parties so the country's critical HIV treatment initiative can continue.
Wider Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a court blocked a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered aid for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
As per reports, 16 African countries have so far signed similar health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens if a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining systems previously set up via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This system is intended to guarantee that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns over the US deal "are not meant as opposition to America," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent co-operation might be arranged in a manner that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that talks must proceed given that a large portion of the nation's HIV programmes relied on external financing.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it commented.
The situation emphasises the ongoing debate between receiving vital foreign assistance and protecting local interests in an ever more interconnected world.